Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Aviva (AV.) by Ben McPoland in The Motley Fool
- Avoid itim Group (ITIM) by Steve Moore in ShareProphets
- Neutral Next (NXT) by Citi
- Avoid TT Electronics (TTG) by Steve Moore in ShareProphets
- Avoid Cyanconnode Holdings (CYAN) by Steve Moore in ShareProphets
- Sell Midwich Group (MIDW) by Steve Moore in ShareProphets
- Buy Smith & Nephew (SN.) by Simon Watkins in The Motley Fool
- Buy BAE Systems (BA.) by Simon Watkins in The Motley Fool
- Hold Wickes Group (WIX) by Deutsche Bank
- Hold Bytes Technology Group (BYIT) by Deutsche Bank
- Buy AstraZeneca (AZN) by Robert Stephens (Telegraph) in The Telegraph - Questor
- Buy Kingfisher (KGF) by Deutsche Bank
- Buy International Consolidated Airlines Group SA (CDI) (IAG) by Deutsche Bank
- Hold BAE Systems (BA.) by Berenberg
- Outperform Hikma Pharmaceuticals (HIK) by Exane
- Buy Lancashire Holdings Limited (LRE) by Goldman Sachs
- Neutral GSK (GSK) by Goldman Sachs
- Buy HSBC Holdings (HSBA) by Goldman Sachs
- Neutral Hiscox Limited (DI) (HSX) by Goldman Sachs
- Buy Beazley (BEZ) by Goldman Sachs
Valirx (VAL) Share Price
Health Care Sector
NOTE: This is based on 6 open tips for Valirx (VAL)
| Latest Bid : 0.50p | Latest Ask : 0.55p |
| High Today : 0.55p | Low Today : 0.50p |
| This Years High : 4.00p | This Years Low : 0.42p |
| Volume : 100,362 | MKT Cap : £0.69M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Valirx (VAL) Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.Valirx (VAL) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |
Valirx (VAL) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.50p | Latest Ask : 0.55p |
| High Today : 0.55p | Low Today : 0.50p |
| This Years High : 4.00p | This Years Low : 0.42p |
| Volume : 100,362 | MKT Cap : £0.69M |
Valirx Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Valirx Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |